Baxion
Screening
Tags
Alerts
Theme
Coya Therapeutics, Inc.
COYA
·
NASDAQ
·
$4.71
Share Price as of 11/2
·
$86M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/11/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/16/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/12/25
Disclosures
Filter
8-K
Current report
10/14/26
8-K
Current report
10/05/26
8-K
Current report
09/15/26
8-K
Current report
08/11/26
8-K/A
Current report (amended)
08/07/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
05/12/26
424B3
Prospectus
03/20/26
S-3
Shelf registration
03/16/26
424B5
Prospectus supplement
10/27/25
424B5
Prospectus supplement
10/23/25
Proxies
Filter
DEF 14A
Definitive proxy
05/13/26
DEFA14A
Additional proxy materials
05/13/26
DEF 14A
Definitive proxy
05/16/25
DEFA14A
Additional proxy materials
05/16/25
DEFA14A
Additional proxy materials
03/29/24
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
07/27/26
Form 3
Initial insider ownership
04/09/26
Form 4
Insider transaction
04/09/26
SC 13G
Beneficial ownership
03/12/26
SC 13G/A
Beneficial ownership (amended)
01/30/26
Other
Filter
ARS
Annual report to shareholders
05/13/26
EFFECT
Request for effectiveness
03/20/26
CORRESP
Correspondence with the SEC
03/19/26
UPLOAD
Letter from the SEC
03/19/26
EFFECT
Request for effectiveness
08/19/25
Latest Filings
Filter
8-K
Current report
10/14/26
8-K
Current report
10/05/26
8-K
Current report
09/15/26
10-Q
Q2 ended 06/30/26
08/11/26
8-K
Current report
08/11/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
07/27/26
Form 3
Initial insider ownership
04/09/26
Form 4
Insider transaction
04/09/26
SC 13G
Beneficial ownership
03/12/26
SC 13G/A
Beneficial ownership (amended)
01/30/26